The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
Jingjing Cai, Haomiao Li, Changjiang Zhang, Ze Chen, Hui Liu, Fang Lei, Juan‐Juan Qin, Ye-Mao Liu, Feng Zhou, Xiaohui Song, Jianghua Zhou, Yan-Ci Zhao, Bin Wu, Meiling He, Huilin Yang, Lihua Zhu, Peng Zhang, Yan‐Xiao Ji, Guang‐Nian Zhao, Zhigang Lu, Li Liu, Weiming Mao, Xiaofeng Liao, Haofeng Lu, Daihong Wang, Xigang Xia, Xiaodong Huang, Wei Xiang, Jiahong Xia, Bing-Hong Zhang, Yufeng Yuan, Zhi‐Gang She, Qingbo Xu, Xinliang Ma, Yibin Wang, Juan Yang, Xin Zhang, Xiao-Jing Zhang, Hongliang Li, Hongliang Li, Hongliang Li
Topics & Concepts
CorticosteroidMedicineNeutrophil to lymphocyte ratioCohortCoronavirus disease 2019 (COVID-19)Diabetes mellitusInternal medicineLymphocyteCohort studyImmunologyDiseaseEndocrinologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Sepsis Diagnosis and Treatment